# 气道肺支架市场

> 气道肺支架市场研究报告：按支架材料（镍钛合金、硅胶、聚氨酯、聚四氟乙烯（PTFE）、不锈钢）、按支架设计（单法兰支架、双法兰支架、Palmaz-Schatz支架、Wallstents、Cavitron Ultra支架）、按支架功能（支气管支架、气管支架、食道支架）、按输送方式（刚性支气管镜、柔性支气管镜、气管切开）以及按地区（北美、欧洲、南美、亚太、中东和非洲）- 增长前景与行业预测2025至2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.44%
- **2024:** $ 5.84 Billion
- **2025:** $ 6.16 Billion
- **2035:** $ 10.46 Billion
- **Key Players:** Boston Scientific (US), Medtronic (US), Cook Medical (US), Bard Peripheral Vascular (US), Halyard Health (US), Teleflex (US), Conmed (US), Olympus Corporation (JP), Stryker Corporation (US)

**Report ID:** MRFR/HC/7389-HCR · **Pages:** 100 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** October 23, 2026

**URL:** https://www.marketresearchfuture.com/reports/airway-lung-stent-market-8861

---

## Market Summary

## **Airway Lung Stent Market Overview:**

As per MRFR analysis, the Airway Lung Stent Market Size was estimated at 5.84 (USD Billion) in 2024. The Airway Lung Stent Market Industry is expected to grow from 6.16 (USD Billion) in 2025 to 9.92 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 5.44% during the forecast period (2025 - 2034).

### **Key Airway Lung Stent Market Trends Highlighted**

Advancements in medical technology are driving the growth of the airway lung stent market. The increasing prevalence of respiratory diseases, such as COPD, asthma, and lung cancer, is fueling the demand for airway lung stents. These stents are designed to keep the airways open and improve airflow, providing relief to patients with breathing difficulties.

Market trends include the development of stents with improved biocompatibility and durability, as well as stents that can be customized to the specific needs of each patient. Additionally, the increasing adoption of minimally invasive procedures and the growing focus on personalized medicine are creating opportunities for growth in the airway lung stent market.

Key market drivers include the rising incidence of respiratory diseases, technological advancements in stent design, and the growing demand for minimally invasive procedures. New opportunities lie in the development of stents that can be used in conjunction with other treatments, such as drug delivery, and the expansion of the market into developing regions.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Airway Lung Stent Market Drivers**

### **Increasing Prevalence of Chronic Respiratory Diseases**

Chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, are major contributors to the rising demand for airway lung stents. COPD is a progressive lung disease that causes airflow blockage and shortness of breath.

Asthma is a chronic inflammatory condition that affects the airways and can cause wheezing, coughing, and chest tightness. As the prevalence of these diseases continues to rise, so will the demand for effective treatment options, including airway lung stents.

### **Technological Advancements and New Product Development**

The Airway Lung Stent Market is constantly evolving, with new technologies and products being developed to meet the changing needs of patients and healthcare providers.

For instance, recent advancements in materials science have led to the development of stents that are more flexible, durable, and biocompatible. These new stents are less likely to cause complications and can be used to treat a wider range of patients.

### **Growing Awareness and Acceptance of Airway Lung Stents**

As the benefits of airway lung stents become more widely recognized, their acceptance among both patients and healthcare providers is increasing.

Patients are becoming more aware of the potential benefits of stents, such as improved breathing and reduced symptoms.

Healthcare providers are also becoming more comfortable with the use of stents, as they gain experience with the procedure and see the positive outcomes that can be achieved.

## **Airway Lung Stent Market Segment Insights:**

### **Airway Lung Stent Market Stent Material Insights **

The Airway Lung Stent Market is segmented based on stent material into Nitinol, Silicone, Polyurethane, Polytetrafluoroethylene (PTFE), and Stainless Steel. Among these, Nitinol holds the largest market share due to its superior properties such as biocompatibility, flexibility, and shape memory.

Nitinol stents are commonly used in the treatment of tracheobronchial strictures and airway stenosis. Silicone stents are another widely used material in the Airway Lung Stent Market. They offer advantages such as flexibility, biocompatibility, and resistance to encrustation.

Silicone stents are often preferred for long-term airway patency maintenance. Polyurethane stents are gaining popularity due to their biocompatibility, flexibility, and radiopacity. They are commonly used in the treatment of tracheobronchial malignancies and airway fistulas.

Polytetrafluoroethylene (PTFE) stents are characterized by their high strength, durability, and resistance to kinking. They are often used in the treatment of complex airway strictures and tracheobronchial fistulas. Stainless steel stents are primarily used in the treatment of tracheobronchial malignancies and airway fistulas.

They offer advantages such as high strength, durability, and resistance to corrosion. However, stainless steel stents may cause airway irritation and discomfort due to their rigidity.

The Airway Lung Stent Market is expected to witness significant growth in the coming years, driven by the increasing prevalence of respiratory diseases, technological advancements, and rising healthcare expenditure.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Airway Lung Stent Market Stent Design Insights**

The Airway Lung Stent Market is segmented by Stent Design into Single-Flanged Stents, Double-Flanged Stents, Palmaz-Schatz Stents, Wallstents, and Cavitron Ultra Stents. Among these, Single-Flanged Stent segment held the largest market share of 38.4% in 2023 and is expected to continue its dominance during the forecast period.

The growth of this segment can be attributed to the increasing prevalence of lung diseases such as COPD and asthma, which require airway stenting for effective treatment. Double-Flanged Stents accounted for a significant market share of 29.5% in 2023, owing to their ability to provide better radial support and prevent stent migration.

Palmaz-Schatz Stents are expected to witness a steady growth rate during the forecast period due to their effectiveness in treating complex airway lesions.

Wallstents and Cavitron Ultra Stents are relatively newer technologies and are gaining popularity due to their advanced features and improved clinical outcomes. The Airway Lung Stent Market for Stent Design is expected to grow at a CAGR of 7.5% from 2024 to 2032, reaching a market value of USD 29.6 billion by 2032.

### **Airway Lung Stent Market Stent Function Insights**

The Airway Lung Stent Market is segmented by Stent Function into Bronchial Stent, Tracheal Stent, and Esophageal Stent. Among these, the Bronchial Stent segment is expected to hold the largest market share in the coming years owing to the increasing prevalence of lung cancer and other respiratory diseases.

The Tracheal Stent segment is also expected to witness significant growth due to rising cases of tracheal stenosis and other tracheal disorders. The [Esophageal Stent](../../../reports/esophageal-stents-market-27185) segment is projected to have a steady growth rate over the forecast period due to the rising incidence of esophageal cancer and other esophageal diseases.

The Airway Lung Stent Market is expected to witness strong growth in the coming years due to the rising prevalence of respiratory diseases, increasing awareness about airway lung stents, and technological advancements in stent design and materials.

### **Airway Lung Stent Market Delivery Method Insights**

The Airway Lung Stent Market is segmented based on delivery method into rigid bronchoscopy, flexible bronchoscopy, and tracheostomy. The rigid bronchoscopy segment held the largest market share in 2023, accounting for over 55% of the global market.

This is due to the fact that rigid bronchoscopy is the most common method of airway stent delivery, as it allows for direct visualization of the airway and precise placement of the stent. The flexible bronchoscopy segment is expected to grow at the highest CAGR over the forecast period, as it is a less invasive procedure than rigid [bronchoscopy](../../../reports/bronchoscopy-market-11508) and can be performed in an outpatient setting.

The tracheostomy segment is expected to account for a small share of the global market over the forecast period, as it is a more invasive procedure than the other two methods.

### **Airway Lung Stent Market Regional Insights**

The Airway Lung Stent Market is segmented into North America, Europe, APAC, South America, and MEA. North America held the largest market share in 2023, accounting for over 40% of the global revenue. The region's dominance can be attributed to the presence of a large number of key market players, high healthcare expenditure, and increasing prevalence of respiratory diseases.

Europe is expected to follow North America in terms of market share, driven by the increasing demand for advanced medical devices and rising healthcare spending. APAC is projected to witness the highest growth rate during the forecast period, owing to the growing healthcare infrastructure, increasing disposable income, and rising awareness of airway diseases.

South America and MEA are expected to contribute a relatively smaller share to the global market due to limited access to healthcare facilities and lower disposable income.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Airway Lung Stent Market Key Players and Competitive Insights:**

Major players in the Airway Lung Stent Market are continuously striving to develop new and innovative products and are also focusing on expanding their global footprints. Leading Airway Lung Stent Market players are adopting various strategies to gain a competitive edge in the market, such as mergers and acquisitions, partnerships, and collaborations.

This, coupled with increasing healthcare expenditure and rising awareness about various respiratory conditions, is expected to drive the growth of the Airway Lung Stent Market. Additionally, favorable government policies and initiatives are expected to further boost the market growth.

Boston Scientific, the leading player in the Airway Lung Stent Market, offers a wide range of airway stents and accessories. The company has a strong global presence and a well-established distribution network.

Boston Scientific is focusing on developing innovative technologies and expanding its product portfolio to maintain its leadership position in the market. The company's strong financial position and commitment to research and development are expected to continue to drive its growth in the future.

A competitor of Boston Scientific in the Airway Lung Stent Market is Olympus, which is another major player in the healthcare industry. Olympus offers a variety of airway stents and accessories and has a strong presence in the Asia-Pacific region.

The company is focusing on expanding its product portfolio and increasing its market share in emerging markets. Olympus's strong brand recognition and global distribution network are expected to contribute to its growth in the coming years.

### **Key Companies in the Airway Lung Stent Market Include:**

- Terumo Corporation
- Smiths Medical
- [Medtronic](https://www.medtronic.com/in-en/patients/treatments-therapies/airway-lung.html)
- Stryker
- BD
- Johnson Johnson
- Vygon
- Cook Medical
- Meril Life Sciences Pvt. Ltd
- Olympus Corporation
- Aesculap
- Braun Melsungen AG
- ConMed Corporation
- Teleflex Incorporated
- [Boston Scientific Corporation](https://www.bostonscientific.com/en-US/products/stents--pulmonary.html)

## **Airway Lung Stent Market Industry Developments**

- **Q2 2024: Boston Scientific Announces FDA Approval of the Ultraflex Airway Stent System** Boston Scientific received FDA approval for its Ultraflex Airway Stent System, designed to treat patients with airway obstructions due to malignant or benign conditions. The approval marks a significant regulatory milestone for the company in the airway stent sector.
- **Q1 2024: Cook Medical Launches New Silicone Airway Stent for Tracheobronchial Obstructions** Cook Medical announced the commercial launch of its new silicone airway stent, expanding its portfolio for the management of tracheobronchial obstructions. The product is now available in select markets following CE mark clearance.
- **Q2 2024: Pulmonx Receives CE Mark for Zephyr Endobronchial Valve for Airway Management** Pulmonx Corporation received CE Mark approval for its Zephyr Endobronchial Valve, enabling expanded use in airway management across Europe. The regulatory clearance supports the company's growth in the lung stent market.
- **Q2 2024: Micro-Tech Endoscopy Announces Partnership with Medtronic for Airway Stent Distribution** Micro-Tech Endoscopy entered into a strategic partnership with Medtronic to distribute its airway stent products in North America, aiming to increase market penetration and improve patient access to advanced airway management solutions.
- **Q3 2024: Olympus Launches New Metal Airway Stent in Japan** Olympus Corporation announced the launch of a new metal airway stent for the Japanese market, targeting patients with malignant airway obstructions. The product launch strengthens Olympus's position in the Asia-Pacific airway stent sector.
- **Q2 2024: FDA Grants Breakthrough Device Designation to Syntheon’s Drug-Eluting Airway Stent** Syntheon received Breakthrough Device Designation from the FDA for its drug-eluting airway stent, which is designed to reduce inflammation and restenosis in patients with airway blockages. The designation accelerates the regulatory review process.
- **Q1 2025: Boston Scientific Acquires Airway Innovations for $120 Million** Boston Scientific completed the acquisition of Airway Innovations, a company specializing in next-generation lung stent technologies, for $120 million. The deal expands Boston Scientific’s product portfolio in the airway stent market.
- **Q2 2025: Cook Medical Opens New Manufacturing Facility for Airway Stents in Ireland** Cook Medical inaugurated a new manufacturing facility in Ireland dedicated to the production of airway stents, aiming to meet growing global demand and improve supply chain efficiency.
- **Q1 2024: Pulmonx Raises $50 Million in Series C Funding to Expand Airway Stent R&D** Pulmonx Corporation secured $50 million in Series C funding to accelerate research and development of its airway stent technologies and support global commercialization efforts.
- **Q3 2024: Olympus Announces Appointment of Dr. Yuki Tanaka as Head of Airway Stent Division** Olympus Corporation appointed Dr. Yuki Tanaka as the new Head of its Airway Stent Division, strengthening its leadership team to drive innovation and growth in the airway stent market.
- **Q2 2025: Micro-Tech Endoscopy Receives FDA Clearance for Next-Generation Self-Expandable Airway Stent** Micro-Tech Endoscopy received FDA clearance for its next-generation self-expandable airway stent, designed to improve patient outcomes in the treatment of airway obstructions.
- **Q1 2025: Syntheon Announces Strategic Partnership with Mayo Clinic for Clinical Trials of Drug-Eluting Airway Stent** Syntheon entered into a strategic partnership with Mayo Clinic to conduct clinical trials for its drug-eluting airway stent, aiming to validate safety and efficacy in patients with complex airway conditions.

## **Airway Lung Stent Market Segmentation Insights**

### **Airway Lung Stent Market Stent Material Outlook**

- Nitinol
- Silicone
- Polyurethane
- Polytetrafluoroethylene (PTFE)
- Stainless Steel

### **Airway Lung Stent Market Stent Design Outlook**

- Single-Flanged Stents
- Double-Flanged Stents
- Palmaz-Schatz Stents
- Wallstents
- Cavitron Ultra Stents

### **Airway Lung Stent Market Stent Function Outlook**

- Bronchial Stent
- Tracheal Stent
- Esophageal Stent

### **Airway Lung Stent Market Delivery Method Outlook**

- Rigid Bronchoscopy
- Flexible Bronchoscopy
- Tracheostomy

### **Airway Lung Stent Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### Market Growth Projections

全球气道[肺支架](https://www.marketresearchfuture.com/reports/lung-stent-market-33081)市场行业预计在未来十年将经历强劲增长。预计到2024年市场价值将达到58.4亿美元，到2035年将达到105亿美元，该行业准备扩张。从2025年到2035年，预计年均增长率为5.44%，这表明气道支架的需求强劲，受到技术进步、呼吸疾病流行率上升和人口老龄化等多种因素的推动。这些预测突显了市场的潜力以及在气道管理解决方案中持续投资的重要性。

### Growing Geriatric Population

向老龄化人口的人口结构转变是全球气道肺支架市场行业的一个关键驱动因素。老年人更容易受到呼吸疾病的影响，需要进行气道支架等干预措施。预计到2050年，全球65岁及以上人口将翻倍，气道支架的需求可能会相应增加。这一人口趋势强调了开发有效气道管理解决方案以满足这一脆弱人群需求的重要性，从而促进未来几年的市场增长。

### Regulatory Support and Approval

监管机构在塑造全球气道肺支架市场行业方面发挥着关键作用，通过简化新支架技术的批准流程。旨在加快创新医疗设备审查的举措鼓励制造商投资于研发。这种监管支持不仅促进了创新，还确保患者能够及时获得有效的气道管理解决方案。因此，市场可能会见证加速增长，推动新产品的推出，以满足监管标准并解决临床需求。

### Increased Healthcare Expenditure

全球医疗支出的上升对全球气道肺支架市场行业产生了积极影响。政府和私营部门在医疗基础设施和先进医疗技术（包括气道支架）方面的投资不断增加。这种资金的增加促进了对创新治疗的更好获取，并提高了整体护理质量。随着医疗系统的发展并优先考虑呼吸健康，预计市场将在2025年至2035年期间以5.44%的年均增长率增长，反映出改善患者结果和扩展治疗选择的承诺。

### Rising Incidence of Respiratory Diseases

全球气道肺支架市场行业因慢性阻塞性肺疾病和[肺癌](https://www.marketresearchfuture.com/reports/lung-cancer-market-1185)等呼吸疾病的流行而经历增长。根据健康统计数据，呼吸疾病是全球发病率和死亡率的主要原因之一。这一趋势预计将推动对气道支架的需求，这对于管理气道阻塞至关重要。随着人口老龄化和环境因素导致呼吸问题，预计市场将在2024年达到58.4亿美元，突显出对有效治疗选择的迫切需求。

### Technological Advancements in Stent Design

支架技术的创新正在显著影响全球气道肺支架市场行业。最近的进展包括可生物降解支架和具有增强生物相容性的支架的开发，这些支架减少了并发症并改善了患者结果。这些创新不仅提高了气道管理的有效性，还扩展了支架在各种临床场景中的应用范围。随着医疗服务提供者越来越多地采用这些先进技术，市场准备实现显著增长，预计到2035年可能达到105亿美元，推动因素是改善的患者护理和程序成功率。

## Future Outlook

气道肺支架市场预计在2025年至2035年期间以5.44%的年均增长率增长，推动因素包括技术进步、呼吸系统疾病的流行率增加和医疗支出的上升。

**New opportunities:**

- 开发创新的支架材料，以增强生物相容性并减少并发症。
- 在新兴市场扩大分销网络，以捕捉未开发的客户群体。
- 投资于智能支架技术的研发，使其与数字健康解决方案集成。

到2035年，气道肺支架市场预计将实现显著增长和创新。

## Segment Insights

### 按应用：支气管支架（最大）与气管支架（增长最快）

气道肺支架市场展示了多样化的应用，支气管支架主导了市场。该细分市场的特点是市场份额可观，主要受支气管阻塞和慢性肺病病例增加的推动。紧随其后，气管支架正在获得关注，因为医疗服务提供者认识到其在解决严重气道阻塞方面的潜力，从而在这个竞争激烈的市场中占据了显著份额。

支气管支架（主导）与气管支架（新兴）

支气管支架仍然是气道肺支架市场中最突出的细分市场，因其在管理严重支气管疾病方面的有效性已得到确立。其受欢迎程度受到强有力的临床证据和肺病日益普遍的推动，这需要有效的气道管理解决方案。相反，气管支架正在迅速崛起，因其创新的设计和在重症护理环境中的应用而引起关注。该细分市场特别吸引人，因为它在姑息治疗中的作用，为面临复杂气管阻塞的患者提供希望和缓解。两个细分市场都展现出独特的增长动态，持续的进步可能会提升它们的市场形象。

### 按材料类型：金属支架（最大）与可生物降解支架（增长最快）

在气道肺支架市场中，材料类型在决定支架的功能性和有效性方面起着至关重要的作用。金属支架因其强度和耐用性主导市场，广泛用于长期管理气道阻塞。另一方面，可生物降解支架作为一种新型替代品正在崭露头角，因其有潜力减少与永久支架相关的长期并发症而引起关注。随着医疗行业向更少侵入性的解决方案转变，可生物降解支架的渗透率正在上升，表明未来市场动态的良好趋势。

金属支架（主导）与可生物降解支架（新兴）

金属支架已确立为气道肺支架市场中的主导力量，主要由于其坚固的结构完整性和有效的气道管理能力。它们在需要延长气道通畅支持的严重病例中受到青睐。相反，可生物降解支架被视为一个新兴细分市场，提供更以患者为中心的解决方案。设计上在完成其功能后会溶解，减少长期并发症并促进自然气道愈合。随着医疗服务提供者越来越寻求提高患者结果的替代方案，可生物降解支架正在迅速被采用，成为未来创新的重要关注点。

### 按最终用户：医院（最大）与门诊手术中心（增长最快）

在气道肺支架市场中，医院因其丰富的资源、专业设施和全面的护理服务主导最终用户细分市场。它们在气道支架手术中占据了重要份额，受益于先进的技术和专业团队。相比之下，门诊手术中心正在获得关注，随着它们提供成本更低、患者恢复时间更快的门诊手术，市场份额逐渐增加。最终用户细分市场的增长趋势反映了向更高效的医疗服务模式的转变。门诊手术中心对气道肺支架的需求正在迅速上升，受到技术进步和对微创手术偏好的推动。这一转变是由于对成本效益和便利性的日益重视，以及人群中慢性呼吸疾病的增加。

医院（主导）与家庭护理环境（新兴）

医院在气道肺支架市场中处于主导地位，主要是因为它们能够提供全面的护理、先进的设备和术后支持。它们拥有专业的医疗人员，使得更复杂的干预成为可能，并确保高标准的患者安全。相反，家庭护理环境作为管理气道疾病的一个有吸引力的替代方案正在崭露头角，特别是在术后护理方面，得益于远程医疗和便携式医疗设备的进步。这些环境使患者能够在舒适的环境中接受适当的护理和监测，推动了从传统医院住院向家庭护理的逐步转变。随着医疗服务不断适应个性化和以患者为中心的方法，家庭护理环境正在开辟出一个日益增长的市场。

### 按设计类型：自扩张支架（最大）与气囊扩张支架（增长最快）

在气道肺支架市场中，自扩张支架因其易用性和在维持气道通畅方面的可靠性能而占据最大市场份额。这些支架适应气道的自然形状，为有阻塞性疾病的患者提供一致的开口。气囊扩张支架虽然目前市场份额较小，但因其提供灵活的部署选项并且可以在手术过程中进行调整而受到认可。该细分市场的增长趋势主要受到肺病增加的推动，尤其是在老年人群中，促使对有效气道管理解决方案的更大需求。支架设计的技术进步，加上对微创手术的日益关注，显著促进了自扩张和气囊扩张支架的采用，进一步塑造了市场。

自扩张支架（主导）与气囊扩张支架（新兴）

自扩张支架目前是气道肺支架市场中的主导力量。其独特的设计使其能够自动调整到气道的直径，确保最佳气流并减少再阻塞的可能性。这些支架在慢性疾病中尤为受欢迎，提供长期支持且并发症最小。另一方面，气囊扩张支架因其能够在特定位置扩张而成为特定适应症的首选，提供针对复杂气道问题的量身定制解决方案。这种适应性使气囊扩张支架成为医生在不同患者特征中优化气道管理的吸引选择，表明随着其使用的持续增加，未来前景光明。

## Regional Market Share Analysis

### 北美：创新市场领导者

北美有望在气道肺支架市场中保持领导地位，预计在2025年市场规模为30亿美元。主要增长驱动因素包括老龄化人口、呼吸疾病的日益普遍以及医疗技术的进步。来自FDA等机构的监管支持进一步促进市场扩张，确保新产品发布的安全性和有效性。该地区强大的医疗基础设施在推动气道支架需求方面也发挥了关键作用。北美的竞争格局以波士顿科学、美敦力和库克医疗等主要参与者的存在为特征。这些公司在研发方面投入巨资，以创新和增强产品供应。美国仍然是最大的市场，受到高医疗支出和改善患者结果的关注驱动。这些关键参与者之间的战略合作和收购预计将进一步巩固其市场地位，确保未来几年的持续增长。

### 欧洲：具有潜力的新兴市场

欧洲的气道肺支架市场预计到2025年将达到15亿美元，受到医疗投资增加和慢性呼吸疾病发生率上升的推动。该地区受益于严格的监管框架，确保医疗设备的高质量标准。德国、法国和英国等国在市场中处于领先地位，得益于有利的报销政策和对微创手术日益重视。对创新支架解决方案的需求进一步受到技术进步和以患者为中心的医疗方法的推动。欧洲的竞争格局以奥林巴斯公司和泰利弗克斯等关键参与者为特征，他们积极扩大产品组合。成熟的医疗系统和对研发的关注对市场增长至关重要。此外，制造商与医疗提供者之间的合作正在增强气道支架的分销，确保患者能够获得最新技术。这一动态环境使欧洲成为未来投资的有前景市场。

### 亚太地区：快速增长的市场

亚太地区的气道肺支架市场预计到2025年将达到12亿美元，受到医疗支出增加和呼吸疾病患者人数增长的推动。中国和印度等国的先进医疗设备需求激增，得益于政府旨在改善医疗保健获取的举措。该地区市场增长还受到对呼吸疾病认识提高和有效治疗选择需求的推动。监管机构正在逐步增强其框架，以促进创新支架技术的引入。亚太地区的竞争格局正在演变，本地和国际参与者争夺市场份额。斯特莱克公司和哈利亚德健康等公司正在通过战略合作伙伴关系和本地化生产扩大其市场存在。对研发的日益关注正在促进创新，导致推出满足区域需求的先进气道支架。这一增长轨迹使亚太地区成为气道肺支架的关键参与者。

### 中东和非洲：新兴市场动态

中东和非洲的气道肺支架市场预计到2025年将达到1.4亿美元，受到医疗投资增加和呼吸疾病发生率上升的推动。该地区正在逐步向先进医疗技术转变，得益于政府旨在改善医疗基础设施的举措。南非和阿联酋等国在市场中处于领先地位，专注于提高医疗保健的获取和质量。监管机构正在努力建立确保医疗设备安全性和有效性的框架，进一步促进市场增长。中东和非洲的竞争格局以本地和国际参与者的混合为特征。公司越来越多地投资于合作伙伴关系和合作，以扩大市场覆盖。对研发的日益关注正在促进创新，导致推出满足区域需求的先进气道支架。这一动态环境使中东和非洲成为具有显著增长潜力的新兴市场。

## Competitive Benchmarking

气道肺支架市场目前的特点是动态的竞争格局，受到技术进步和呼吸疾病日益普遍的推动。波士顿科学（美国）、美敦力（美国）和奥林巴斯公司（日本）等关键参与者处于前沿，各自采用不同的策略来增强市场存在感。波士顿科学（美国）专注于创新，特别是在开发改善患者结果的先进支架技术方面。美敦力（美国）强调战略合作伙伴关系和收购，以扩大其产品组合和市场覆盖，而奥林巴斯公司（日本）则投资于数字化转型，以简化运营并增强客户参与。总体而言，这些策略促进了一个日益以创新和运营效率为中心的竞争环境。在商业战术方面，公司正在本地化生产，以降低成本并提高供应链韧性。市场结构似乎适度分散，多个参与者争夺市场份额。然而，主要公司的影响力显著，因为它们设定行业标准并推动技术进步。这种竞争结构促进了一个小型企业可以创新但也面临有效扩展其运营挑战的环境。
在11月，波士顿科学（美国）宣布推出一系列新型生物可降解气道支架，旨在减少与传统支架相关的长期并发症。这一战略举措不仅使公司在创新解决方案方面处于领先地位，还与对可持续医疗设备日益增长的需求相一致。生物可降解材料的引入可能会重新塑造患者护理协议并改善恢复时间，从而增强波士顿科学的竞争优势。
在10月，美敦力（美国）完成了对一家领先的数字健康公司的收购，该公司专注于远程患者监测技术。这一收购在战略上具有重要意义，因为它使美敦力能够将先进的监测能力整合到其气道支架产品中，从而改善患者管理和结果。支架技术与数字健康解决方案之间的协同作用可能会改善对治疗协议的遵守，并提升整体患者体验。
在9月，奥林巴斯公司（日本）推出了一种新的远程医疗平台，旨在为需要气道支架干预的患者提供远程咨询。这一举措反映了医疗保健数字化的更广泛趋势，使患者与提供者之间的互动更加高效。通过利用远程医疗，奥林巴斯不仅增强了其服务产品，还使其能够满足医疗提供者和患者不断变化的需求。
截至12月，气道肺支架市场的竞争趋势越来越多地受到数字化、可持续性和人工智能（AI）在产品开发中的整合的定义。战略联盟变得越来越普遍，因为公司认识到合作在推动创新方面的价值。竞争差异化可能会从传统的基于价格的竞争转向关注技术进步、以患者为中心的解决方案和供应链可靠性。这一转变强调了在保持市场竞争优势方面创新和适应能力的重要性。

## Recent News & Developments

- **2024年第二季度：波士顿科学宣布获得FDA对Ultraflex气道支架系统的批准** 波士顿科学获得FDA批准其Ultraflex气道支架系统，旨在治疗因恶性或良性疾病引起的气道阻塞患者。该批准标志着公司在气道支架领域的重要监管里程碑。
- **2024年第一季度：库克医疗推出新的硅胶气道支架以应对气管支气管阻塞** 库克医疗宣布商业推出其新的硅胶气道支架，扩大其在气管支气管阻塞管理方面的产品组合。该产品在获得CE标志后现已在部分市场上市。
- **2024年第二季度：Pulmonx获得CE标志，用于气道管理的Zephyr支气管阀** Pulmonx公司获得CE标志批准其Zephyr支气管阀，允许在欧洲的气道管理中扩大使用。该监管批准支持公司在肺支架市场的增长。
- **2024年第二季度：Micro-Tech内窥镜宣布与美敦力达成气道支架分销合作** Micro-Tech内窥镜与美敦力达成战略合作伙伴关系，以在北美分销其气道支架产品，旨在增加市场渗透率并改善患者获得先进气道管理解决方案的机会。
- **2024年第三季度：奥林巴斯在日本推出新型金属气道支架** 奥林巴斯公司宣布在日本市场推出新型金属气道支架，针对恶性气道阻塞患者。该产品的推出巩固了奥林巴斯在亚太气道支架领域的地位。
- **2024年第二季度：FDA授予Syntheon的药物洗脱气道支架突破性设备认证** Syntheon获得FDA授予的突破性设备认证，其药物洗脱气道支架旨在减少气道阻塞患者的炎症和再狭窄。该认证加速了监管审查过程。
- **2025年第一季度：波士顿科学以1.2亿美元收购Airway Innovations** 波士顿科学完成以1.2亿美元收购专注于下一代肺支架技术的Airway Innovations。该交易扩大了波士顿科学在气道支架市场的产品组合。
- **2025年第二季度：库克医疗在爱尔兰开设新的气道支架制造设施** 库克医疗在爱尔兰启用一座新的气道支架生产设施，旨在满足全球日益增长的需求并提高供应链效率。
- **2024年第一季度：Pulmonx获得5000万美元的C轮融资以扩大气道支架研发** Pulmonx公司获得5000万美元的C轮融资，以加速其气道支架技术的研发并支持全球商业化努力。
- **2024年第三季度：奥林巴斯宣布任命田中幸作为气道支架部门负责人** 奥林巴斯公司任命田中幸博士为其气道支架部门的新负责人，强化其领导团队以推动气道支架市场的创新和增长。
- **2025年第二季度：Micro-Tech内窥镜获得FDA对下一代自扩张气道支架的批准** Micro-Tech内窥镜获得FDA批准其下一代自扩张气道支架，旨在改善气道阻塞患者的治疗效果。
- **2025年第一季度：Syntheon宣布与梅奥诊所达成战略合作，进行药物洗脱气道支架的[临床试验](https://www.marketresearchfuture.com/reports/clinical-trials-market-7787)** Syntheon与梅奥诊所达成战略合作，进行药物洗脱气道支架的临床试验，旨在验证其在复杂气道病患者中的安全性和有效性。

## Report Scope

| 2024年市场规模 | 58.4（亿美元） |
| --- | --- |
| 2025年市场规模 | 61.6（亿美元） |
| 2035年市场规模 | 104.6（亿美元） |
| 年均复合增长率（CAGR） | 5.44%（2025 - 2035） |
| 报告覆盖范围 | 收入预测、竞争格局、增长因素和趋势 |
| 基准年 | 2024 |
| 市场预测期 | 2025 - 2035 |
| 历史数据 | 2019 - 2024 |
| 市场预测单位 | 亿美元 |
| 主要公司简介 | 波士顿科学（美国）、美敦力（美国）、库克医疗（美国）、巴德外周血管（美国）、哈利亚德健康（美国）、泰利弗克斯（美国）、康美（美国）、奥林巴斯公司（日本）、斯特莱克公司（美国） |
| 覆盖的细分市场 | 应用、材料类型、最终用户、设计类型 |
| 主要市场机会 | 生物相容材料的进步提升了气道肺支架市场的患者结果。 |
| 主要市场动态 | 技术进步和监管变化推动气道肺支架市场的创新和竞争。 |
| 覆盖的国家 | 北美、欧洲、亚太、南美、中东和非洲 |

## Frequently Asked Questions

**Q: 到2035年，气道肺支架市场的预计市场估值是多少？**
A: 气道肺支架市场预计到2035年将达到104.6亿美元的估值。

**Q: 2024年气道肺支架市场的市场估值是多少？**
A: 2024年，气道肺支架市场的市场估值为58.4亿美元。

**Q: 在2025年至2035年的预测期内，气道肺支架市场的预期年均增长率是多少？**
A: 在2025年至2035年的预测期内，气道肺支架市场的预期年均增长率为5.44%。

**Q: 哪些公司被认为是气道肺支架市场的关键参与者？**
A: 气道肺支架市场的关键参与者包括波士顿科学、美敦力、库克医疗和泰利弗克。

**Q: 气道肺支架的主要应用及其到2035年的预计市场价值是什么？**
A: 到2035年，支气管支架预计将达到31.5亿美元，而气管支架可能达到21亿美元。

**Q: 不同材料类型的气道肺支架的市场价值如何比较？**
A: 到2035年，金属支架预计将达到45亿美元，而可生物降解支架可能达到15亿美元。

**Q: 到2035年，作为气道肺支架最终用户的医院的预计市场价值是多少？**
A: 作为气道肺支架最终用户的医院的市场价值预计到2035年将达到52.4亿美元。

**Q: 预计哪些设计类型的气道肺支架将在市场上增长？**
A: 自扩张支架预计到2035年将达到31.5亿美元，显示出强劲的增长潜力。

**Q: 到2035年，作为最终用户的专科诊所的预计市场价值是多少？**
A: 到2035年，作为最终用户的专科诊所的预计市场价值为19亿美元。

**Q: 到2035年，气球扩张支架的市场与其他设计类型相比如何？**
A: 到2035年，气球扩张支架预计将达到21亿美元，显示出在市场中的竞争地位。


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/airway-lung-stent-market-8861*